Brooklyn Immunotherapeutics Inc (NASDAQ:BTX)

6.19
Delayed Data
As of Nov 26
 -0.51 / -7.55%
Today’s Change
3.59
Today|||52-Week Range
80.67
+38.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues24.5M22.3M21.3M23.3M
 
 
 
 
 
Cost of Goods Sold10.0M5.2M4.8M5.6M
 
 
 
 
 
Depreciation And Amortization3.1M2.9M2.3M2.8M
 
 
 
 
 
 
Operating ExpensesGross Income11.5M14.2M14.2M15.0M
 
 
 
 
 
General Expenses18.1M16.5M15.6M14.5M
 
 
 
 
 
Research And Development----0.0072.0K
 
 
Total Operating Expenses31.1M24.6M22.7M22.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-2.3M-1.4M464.0K
 
 
 
 
 
Extraordinary Charge-295.0K0.000.00-261.0K
 
 
 
Interest Expense On Debt484.0K576.0K498.0K389.0K
 
 
 
 
 
Other Expenses162.0K-31.0K889.0K-137.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.2M-2.9M-1.0M-323.0K
 
 
 
 
 
Income Taxes-12.0K-38.0K-66.0K-64.0K
 
 
 
 
 
Preferred Dividend0.00-----16.0K
 
 
Net Income-7.2M-2.9M-1.1M-259.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M1.9M2.4M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M1.9M2.4M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$1.54-$0.44-$0.10
 
 
 
 
 
EPS Diluted-$4.00-$1.54-$0.44-$0.10